SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001104659-20-062698
Filing Date
2020-05-15
Accepted
2020-05-15 16:46:49
Documents
56
Period of Report
2020-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q tm2014566d1_10q.htm 10-Q 548448
2 EXHIBIT 4.1 tm2014566d1_ex4-1.htm EX-4.1 107825
3 EXHIBIT 4.2 tm2014566d1_ex4-2.htm EX-4.2 113153
4 EXHIBIT 31.1 tm2014566d1_ex31-1.htm EX-31.1 7069
5 EXHIBIT 31.2 tm2014566d1_ex31-2.htm EX-31.2 7102
6 EXHIBIT 32.1 tm2014566d1_ex32-1.htm EX-32.1 3700
7 EXHIBIT 32.2 tm2014566d1_ex32-2.htm EX-32.2 3679
  Complete submission text file 0001104659-20-062698.txt   4254169

Data Files

Seq Description Document Type Size
8 XBRL INSTANCE DOCUMENT capr-20200331.xml EX-101.INS 821789
9 XBRL TAXONOMY EXTENSION SCHEMA capr-20200331.xsd EX-101.SCH 47840
10 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE capr-20200331_cal.xml EX-101.CAL 29642
11 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE capr-20200331_def.xml EX-101.DEF 159911
12 XBRL TAXONOMY EXTENSION LABEL LINKBASE capr-20200331_lab.xml EX-101.LAB 336630
13 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE capr-20200331_pre.xml EX-101.PRE 285158
Mailing Address 8840 WILSHIRE BLVD 2ND FLOOR BEVERLY HILLS CA 90211
Business Address 8840 WILSHIRE BLVD 2ND FLOOR BEVERLY HILLS CA 90211 (310) 358-3200
CAPRICOR THERAPEUTICS, INC. (Filer) CIK: 0001133869 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-34058 | Film No.: 20886229
SIC: 2834 Pharmaceutical Preparations